Feed/Companies/Crystalys Therapeutics

Crystalys Therapeutics

As of 14 Oct 2026, Crystalys Therapeutics has raised $205M across 1 verified round on record; latest: $205 million Series A led by Catalys Pacific, Novo Holdings and 1 other, announced 30 Sep 2025.

BUILT ON

Visit site

Crystalystx develops therapeutics specifically for treating gout.

crystalystx.comSan Diego, CaliforniaBiotech

LATEST ROUND

Series A

$205M · 2025-09-30

RAISED ON RECORD · USD

$205M

across 1 verified round

INVESTORS

3 leads

SOURCES

from 1 publisher

Rounds

[ 1

Feed/Companies

Company

Every round on record, with the sources behind each and the investors on them.

BUILT ON

Series A

$205M · 2025-09-30

[ HISTORY ]

led by Catalys Pacific, Novo Holdings, SR One

Round	Amount	Announced	Lead	Buzz
Series A [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$205M	2025-09-30	Catalys Pacific, Novo Holdings, SR One	No recent discussion
1 source [ VERIFIED ] read against 1 source HQ added San Diego, California · prnewswire.com The company's release is the announcement source; no conflicting source was provided.

Crystalys Therapeutics

Rounds

Company

Rounds

Sources

Profile

Investors

Crystalys Therapeutics

Rounds

Profile

Sources

Series A$205M2025-09-301 source

Investors

Series A$205M2025-09-3013 investors